Dynamic Technology Lab Private Ltd Takes $299,000 Position in Omega Healthcare Investors, Inc. (NYSE:OHI)

Dynamic Technology Lab Private Ltd purchased a new position in Omega Healthcare Investors, Inc. (NYSE:OHI) in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 7,326 shares of the real estate investment trust’s stock, valued at approximately $299,000.

Other large investors also recently added to or reduced their stakes in the company. Daiwa Securities Group Inc. increased its stake in shares of Omega Healthcare Investors by 317.7% during the third quarter. Daiwa Securities Group Inc. now owns 3,949,368 shares of the real estate investment trust’s stock worth $160,739,000 after purchasing an additional 3,003,845 shares in the last quarter. Charles Schwab Investment Management Inc. increased its stake in Omega Healthcare Investors by 6.7% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 3,830,302 shares of the real estate investment trust’s stock worth $155,893,000 after buying an additional 240,006 shares in the last quarter. Dimensional Fund Advisors LP raised its holdings in shares of Omega Healthcare Investors by 7.9% during the second quarter. Dimensional Fund Advisors LP now owns 3,732,390 shares of the real estate investment trust’s stock valued at $127,831,000 after acquiring an additional 272,299 shares during the last quarter. Bank of New York Mellon Corp lifted its position in shares of Omega Healthcare Investors by 4.6% in the second quarter. Bank of New York Mellon Corp now owns 3,240,025 shares of the real estate investment trust’s stock valued at $110,971,000 after acquiring an additional 143,521 shares in the last quarter. Finally, LSV Asset Management boosted its stake in shares of Omega Healthcare Investors by 0.7% in the second quarter. LSV Asset Management now owns 1,968,200 shares of the real estate investment trust’s stock worth $67,411,000 after acquiring an additional 14,000 shares during the last quarter. 65.25% of the stock is currently owned by institutional investors and hedge funds.

Omega Healthcare Investors Price Performance

OHI stock opened at $40.61 on Monday. Omega Healthcare Investors, Inc. has a 52-week low of $27.53 and a 52-week high of $44.42. The company has a quick ratio of 6.48, a current ratio of 6.48 and a debt-to-equity ratio of 1.10. The stock has a market cap of $10.96 billion, a price-to-earnings ratio of 29.86, a price-to-earnings-growth ratio of 1.26 and a beta of 0.99. The business has a fifty day moving average of $40.61 and a two-hundred day moving average of $37.40.

Omega Healthcare Investors Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, November 15th. Investors of record on Monday, November 4th were issued a $0.67 dividend. The ex-dividend date of this dividend was Monday, November 4th. This represents a $2.68 annualized dividend and a yield of 6.60%. Omega Healthcare Investors’s dividend payout ratio (DPR) is currently 197.06%.

Analyst Upgrades and Downgrades

A number of brokerages have weighed in on OHI. Scotiabank raised their price objective on Omega Healthcare Investors from $33.00 to $39.00 and gave the company a “sector perform” rating in a report on Monday, August 26th. Truist Financial boosted their price target on shares of Omega Healthcare Investors from $33.00 to $39.00 and gave the stock a “hold” rating in a research report on Wednesday, September 4th. Wells Fargo & Company reissued an “overweight” rating and issued a $43.00 target price (up from $40.00) on shares of Omega Healthcare Investors in a research note on Tuesday, October 1st. Berenberg Bank assumed coverage on Omega Healthcare Investors in a research report on Friday, October 18th. They issued a “buy” rating and a $45.00 price target for the company. Finally, Royal Bank of Canada increased their price target on Omega Healthcare Investors from $39.00 to $43.00 and gave the company a “sector perform” rating in a report on Monday, November 11th. Seven investment analysts have rated the stock with a hold rating and five have given a buy rating to the company’s stock. According to MarketBeat.com, Omega Healthcare Investors has a consensus rating of “Hold” and an average target price of $40.00.

Insider Buying and Selling at Omega Healthcare Investors

In other Omega Healthcare Investors news, COO Daniel J. Booth sold 56,725 shares of the company’s stock in a transaction on Friday, September 27th. The stock was sold at an average price of $40.25, for a total transaction of $2,283,181.25. Following the transaction, the chief operating officer now directly owns 100,000 shares in the company, valued at $4,025,000. This represents a 36.19 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CFO Robert O. Stephenson sold 22,542 shares of the firm’s stock in a transaction on Friday, September 27th. The stock was sold at an average price of $40.19, for a total value of $905,962.98. Following the transaction, the chief financial officer now owns 183,076 shares of the company’s stock, valued at approximately $7,357,824.44. This represents a 10.96 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.37% of the stock is currently owned by corporate insiders.

Omega Healthcare Investors Profile

Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.